Press Releases Nanobiotix

Equities

NANO

FR0011341205

Market Closed - Euronext Paris Other stock markets 11:35:23 2024-04-29 am EDT			After market 01:33:40 pm
5.49 ^EUR	+0.73%		5.495	+0.09%

Apr. 25	Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024
Apr. 24	Nanobiotix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results	Apr. 24	GL
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024	Apr. 17	GL
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation	Apr. 02	GL
Nanobiotix to Present at Upcoming Investor Conferences in March	Mar. 06	GL
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference	Jan. 31	GL
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference	Jan. 31	AQ
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study	Jan. 29	GL
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets	Dec. 26	GL
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.	Dec. 04	GL
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.	Dec. 04	GL
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.	Dec. 04	AQ
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update	Nov. 13	GL
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update	Nov. 13	AQ
NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023	Nov. 09	GL
NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023	Nov. 09	AQ
NANOBIOTIX Announces Closing of Global Offering	Nov. 07	GL
NANOBIOTIX Announces Closing of Global Offering	Nov. 07	GL
NANOBIOTIX Announces Closing of Global Offering	Nov. 07	AQ
Nanobiotix : Underwriting Agreement - Form 6-K	Nov. 07	PU
NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M	Nov. 06	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nanobiotix

Equities

NANO

FR0011341205

Press Releases

Filters